The lactate-to-albumin ratio as a potential biomarker for short-term mortality risk in critically ill patients with urosepsis: a retrospective study with dual-cohort validation - PubMed
4 hours ago
- #mortality risk
- #biomarker
- #urosepsis
- The lactate-to-albumin ratio (LAR) is explored as a biomarker for short-term mortality risk in critically ill urosepsis patients.
- The study used data from MIMIC-IV and an external validation cohort, analyzing 1,055 urosepsis patients.
- Higher LAR was significantly associated with increased ICU and in-hospital mortality rates.
- A non-linear positive dose-response relationship was found between LAR and mortality.
- A risk model incorporating LAR and other variables showed superior predictive performance compared to traditional scores.
- LAR is suggested as a cost-effective tool for early identification of high-risk urosepsis patients.